Shu Fen Wen
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 5%
- Biotechnology top 2%
- Immunology
- Co-authors
- Suxing LiuLoretta L. NielsenLuquan WangHena R. AsharW. Robert BishopQun WuAsra MirzaStuart Black
- Topics
- Virus-based gene therapy research (11 papers)Cancer Research and Treatments (6 papers)Cancer-related Molecular Pathways (6 papers)
- Cited by
- BiotechnologyOncologyGenetics
- Partner nations
- United StatesChinaGermany
In The Last Decade
Shu Fen Wen
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 857
- Oncology 626
- Genetics 466
- Biotechnology 258
- Immunology 132
Countries citing papers authored by Shu Fen Wen
This map shows the geographic impact of Shu Fen Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Fen Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Fen Wen more than expected).
Fields of papers citing papers by Shu Fen Wen
This network shows the impact of papers produced by Shu Fen Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Fen Wen. The network helps show where Shu Fen Wen may publish in the future.
Co-authorship network of co-authors of Shu Fen Wen
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Fen Wen. A scholar is included among the top collaborators of Shu Fen Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Fen Wen. Shu Fen Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 18 | |
| 3 | 45 | |
| 4 | 21 | |
| 5 | 50 | |
| 6 | 13 | |
| 7 | 69 | |
| 8 | 35 | |
| 9 | 462 | |
| 10 | 105 | |
| 11 | 41 | |
| 12 | 6 | |
| 13 | 44 | |
| 14 | 28 | |
| 15 | p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. | 79 |
| 16 | Wild-type and mutant retinoblastoma protein in paraffin sections. | 43 |
| 17 | 17 | |
| 18 | 204 |
About Shu Fen Wen
Shu Fen Wen is a scholar working on Biotechnology, Developmental Neuroscience and Genetics, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Cancer Research and Treatments (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Biotechnology (258 citations), Oncology (626 citations) and Genetics (466 citations). Shu Fen Wen has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Suxing Liu, Loretta L. Nielsen, Luquan Wang, Hena R. Ashar, W. Robert Bishop, Qun Wu, Asra Mirza, Stuart Black, Cecil B. Pickett and Paul T. Kirschmeier. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.